Floatz logo

Lcar-Aio T Cells

Myasthenia Gravis

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Myasthenia Gravis cohort.

Asset / SponsorPhaseRating
Etoposide
Fred Hutchinson Cancer Center
Phase 2CCC
Melphalan
Fred Hutchinson Cancer Center
Phase 2CCC
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2CCC
Cytarabine
Fred Hutchinson Cancer Center
Phase 2CCC
Prednisone
Fred Hutchinson Cancer Center
Phase 2CCC

View all 22 →

Same molecule, other indications

Lcar-Aio T Cells is also rated in:

multiple sclerosisActive
CC
Indicative · Phase 1
43 / 100
View asset →
neuromyelitis opticaActive
CC
Indicative · Phase 1
43 / 100
View asset →
myelin oligodendrocyte glycoprotein antibody-associated diseaseActive
CC
Indicative · Phase 1
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →